NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/13/2023
Back to search
Official data from USPTO
NEO-SYNEPHRINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NEO-SYNEPHRINE
ST13
US500000071465327Class
1, 6
Filing
71465327
Registration
406720
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/13/2023
Classification
Registered
Trademark type
Word
Nice classes
1, 6
Filing date
11/26/1943
Registration date
04/18/1944
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/13/2023
Last transaction
10/13/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/13/1943
First use in commerce
01/13/1943
Drawing code
1
Owner type
03
Owner location
Lenexa, KS, US
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
B.F. ASCHER & COMPANY, INC.
FOUNDATION CONSUMER HEALTHCARE, LLC
BAYER HEALTHCARE LLC
Sterling Drug, Inc.
Frederick Stearns & Company
Representatives
Scott R. Brown Hovey Williams LLP
Technical classification
Nice Classes
Class 1Class 6
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
No specification.
Class 6
Preparation Used as a Vasoconstrictor Having Local and Systemic Actionfor Prolonging Local Anesthesia and for Hemostasisas a Diuretic and/or Antidiureticto Lessen Asthenia. and as an Antispasmodic
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL5
REGISTERED AND RENEWED (FIFTH RENEWAL - 10 YRS)
10/13/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/13/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
04/21/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/18/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/17/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/24/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/30/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/12/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/12/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/03/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/08/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/28/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/28/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/24/2014
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/22/2014
P12C
PUBLISHED SECTION 12(C)
04/22/2014
RNL4
REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)
04/22/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/22/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
04/04/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
04/04/2014
12AF
SECTION 12(C) AFFIDAVIT FILED
04/03/2014
CFIT
CASE FILE IN TICRS
10/07/2008
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
12/29/2003
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/29/2003
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
10/16/2003
E89R
TEAS SECTION 8 & 9 RECEIVED
10/16/2003
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/19/2002
REN2
REGISTERED AND RENEWED (SECOND RENEWAL - 20 YRS)
04/18/1984
Continuous trademark protection
Get notified about every new filing that threatens NEO-SYNEPHRINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.